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Abstract
Background Burn injury results in a chronic inflammatory,
hypermetabolic, and hypercatabolic state persisting long
after initial injury and wound healing. Burn survivors expe-
rience a profound and prolonged loss of lean body mass, fat
mass, and bone mineral density, associated with significant
morbidity and reduced quality of life. Understanding the
mechanisms responsible is essential for developing thera-
pies. A complete characterization of the pathophysiology of
burn cachexia in a reproducible mouse model was lacking.
Methods Young adult (12–16 weeks of age) male C57BL/6J
mice were given full thickness burns using heated brass
plates or sham injury. Food and water intake, organ and
muscle weights, and muscle fiber diameters were measured.
Body composition was determined by Piximus. Plasma
analyte levels were determined by bead array assay.
Results Survival and weight loss were dependent upon burn
size. The body weight nadir in burned mice was 14 days, at
which time we observed reductions in total body mass, lean
carcass mass, individual muscle weights, and muscle fiber
cross-sectional area. Muscle loss was associated with in-
creased expression of the muscle ubiquitin ligase, MuRF1.
Burned mice also exhibited reduced fat mass and bone
mineral density, concomitant with increased liver, spleen,
and heart mass. Recovery of initial body weight occurred at
35 days; however, burned mice exhibited hyperphagia and
polydipsia out to 80 days. Burned mice had significant
increases in serum cytokine, chemokine, and acute phase
proteins, consistent with findings in human burn subjects.
Conclusions This study describes a mouse model that largely
mimics human pathophysiology following severe burn injury.
These baseline data provide a framework for mouse-based
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1 Introduction
According to statistics provided by the American Burn
Association [1], there are 450,000 burns annually in the
USA, of which 3,500 result in death. There are 45,000
hospitalizations for burn injury, with 31% of burns exceed-
ing 10% total body surface area (TBSA) and 11% exceeding
20% TBSA [2]. Worldwide, burn injuries are on the rise due
to increased industrialization, escalating conflicts and the
use of white phosphorus on battlefields. Fortunately, advan-
ces in burn care are resulting in greater survival for patients
with severe burns; however, this increases the need for long-
term care of these challenging patients through the acute
post-burn period into the convalescent period [3, 4].
Morbidity and mortality are associated with burn size [1].
Severe burn injuries are associated with a significant inflam-
matory, hypermetabolic (increased body temperature, oxy-
gen and glucose consumption, and CO2 production), and
hypercatabolic (increased lipolysis, proteolysis, glycogenol-
ysis) state, with hepatosplenomegaly that arises acutely and
persists chronically. Studies have shown that this profound
and prolonged hypermetabolic and hyperinflammatory state
persist for up to 3 years after initial burn injury and even
following wound healing [3–5]. Consequently, patients
develop a systemic loss of muscle mass, lean body
mass, and bone mineral density [3–6]. Patients with a
40% TBSA burn can lose up to 25% of their total body
mass in 3–4 weeks, with generally fatal consequences
[5, 7]. Lesser weight loss of even 10–15%, however, is
associated with significantly increased rates of infection and
reduced wound healing. Such persistent inflammation and
cachexia is common in all trauma, surgical and critically ill
patients, and many forms of chronic diseases, but the severity
and chronicity in burn patients is unique [8]. In all cases,
weight loss and the rate of weight loss are closely correlated
with mortality [9].
The metabolic response to burn injury is character-
ized by changes in protein metabolism occurring in
multiple organs and tissues. The breakdown of skeletal
muscle, the largest protein and amino acid stores in the
body, through increased proteolysis, leads to negative nitrogen
balance and whole-body protein loss [5, 10, 11]. Muscle wast-
ing is exacerbated by insulin and insulin-like growth factor
resistance leading to reduced anabolism [12]. The imbalance in
anabolic and catabolic pathways leads to muscle atrophy,
weakness, and debilitation. In contrast, protein synthesis and
anabolic pathways are increased in the liver and intestinal
mucosa. Indeed, hepatomegaly and splenomegaly are fre-
quently observed and are likely in large part due to induction
of the acute phase response and increased hepatic protein
synthetic capacity [13, 14].
Although investigators have used mouse models to dis-
sect molecular pathways altered after burn injury [15–18], to
date no single study has measured the long-term effects of
burn injury on body weight, muscle weight, fat weight, bone
mass, and food and water intake in a mouse model. This
basic information is necessary to provide a framework and
baseline for evaluating the mechanisms underlying burn-
injury-associated cachexia. Moreover, although the burn
response in humans scales with percentage of body surface
burned, most reported murine models employ fixed tem-
plates for scald or flame injury, an approach that does not
permit fine adaptation of the burn area for mice of differing
sizes and shapes. Finally, although heightened food intake
has been reported in rats after burn injury, an absence of
publications on the murine response has led to referees
asking for pair-fed models. Taken together the absence of
muscle-specific data, the variation inherent in existing mod-
els, and confusion in the field regarding food intake, we
sought to develop a robust, reproducible, well-documented
model of burn-injury-associated cachexia in mice.
In this model, similar to human burn patients, mice show
reduced total body weight, fat, and lean body mass persisting
long after initial injury and wound healing. We also observed
loss of bone mineral density, hepatosplenomegaly and car-
diac hypertrophy. Using samples from mice at the nadir of
body weight, we also measure muscle fiber morphometry,
cytokine/chemokine/acute phase protein levels, and muscle
gene expression. We anticipate these data will prove useful for
further analysis of pathways mediating burn-injury-associated
cachexia and likely other metabolic sequelae.
2 Methods
2.1 Mice
All experiments were approved by the University of Miami
and Thomas Jefferson University Institutional Animal Care
and Use Committees. Mice were cared for in accordance
with the National Research Council’s Guide for the Care
and Use of Laboratory Animals. Male C57BL/6J mice
(Jackson Laboratory, Bar Harbor, ME, USA) 12–16 weeks
old were acclimated to the colony for at least 1 week prior to
injury with free access to standard chow and water and a 12-
h light–dark cycle in standard acrylic cages with paper or
wood chip bedding. While mice were specific pathogen free
or virus antibody free at time of purchase, the mice de-
scribed were housed in a conventional facility without
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barrier housing, autoclaving, sterile cages, or negative pres-
sure. Mice were housed four per cage until the day of injury
in acrylic cages with wire tops and plastic filter lids. Mice
were fed certified rodent diet LabDiet 5002 (Purina), with
20% protein, 4.5% fat, 5.5% fiber by weight, and carbohy-
drates 63%, protein 24%, and fat 13% by caloric value.
Mice were randomly allocated into the burn or sham groups,
although we ensured subsequently that the starting weights
of each group were not statistically different.
2.2 Brass plate assembly
Brass plates measuring 2×2×0.25, 1×1×0.25, or 1×2×
0.25 cm were cut from brass plate stock (Small Parts,
Amazon.com) then welded to metal screws. This assembly
was then screwed into the ends of Teflon/PTFE round rods
(www.smallparts.com) cut to size. This work was done in
the machine shop at the University of Miami.
2.3 Burn injury
On the day of burn injury, anesthesia was induced using
inhaled 1–3% isoflurane with supplemental oxygen and
maintained with an intra-peritoneal injection of 100 mg/kg
ketamine (Ketaset, Fort Dodge Animal Health, Fort Dodge,
IA, USA) and 15 mg/kg xylazine (TranquiVed, Vedco, St.
Joseph, MO, USA). After adequate sedation was achieved,
the fur was removed by close shaving with clippers. Resid-
ual hair stubble was removed with the application of Nair©
as per the manufacturer’s instructions. Mice were then
washed, dried, and weighed, and total body surface area
was calculated according to the Meeh equation, BSA0k
mass0.667, where BSA is body surface area expressed in
square centimeters and mass is expressed in grams, using
the constant k09.822 as we previously determined [19].
Mice were given a first dose of buprenorphine (s.c.
0.1 mg/kg in 0.1 cc, Buprenex, Rechitt Benchiser, Hull,
England) to ensure effective analgesia upon wakening. The
plate-rod contraption was immersed in a water bath (100°C)
and blotted dry prior to use to avoid steam injury. Burn
injuries were induced by balancing the brass plates/rods
assembly on the dry dorsum with full skin contact, taking
care to avoid the spine and upper and lower extremities. The
dorsal surface was used rather than the ventral to avoid
organ damage. Duration of contact was varied from 5 to
20 s but in the final model consisted of 5 s of contact.
Uniform contact was confirmed by the resulting red coloration
of the skin observed after removal of the plate. Additional
burns were made with appropriate area brass plates in order to
achieve the desired TBSA burn percentage.
Mice were resuscitated immediately following burn injury
with a single intra-peritoneal injection of Lactated Ringer’s,
2 cc/kg/% BSA burned. Trials of resuscitation with 4 cc/kg/%
BSA and 6 cc/kg/%BSAwere also performed. Buprenorphine
(dosed as first) was administered every 12 h after burn for a
total of six doses. Sham animals did not receive Nair©
[because it induces a chemical burn and subsequent
inflammation and muscle wasting, (unpublished data)]
or burns but were given anesthesia, shaved, and provid-
ed fluid resuscitation and buprenorphine similar to the
experimental group. Following burn injury, mice were
housed individually with free access to food and drink-
ing water and were weighed at the same time daily.
Food and water intake were also measured daily in
certain experiments by weighing the food and water
bottle on day 1, then weighing the remaining food and
water bottle the next day. Food and water consumed
were calculated as the difference between starting and
ending weights. Some mice persistently shredded the
chow pellets, leaving noticeable quantities of crumbs on the
cage floor. These rare mice (1–2 in 40) were excluded from
the analysis.
2.4 Survival analysis
As much as possible, mice were not allowed to undergo
spontaneous death because such death is not permitted as an
endpoint according to the universities’ standards for the
humane and ethical treatment of research animals. If mice
became moribund and displayed low to no motility, hunched
posture, and declining body temperature, they were
humanely euthanized and recorded as a death. Since most
deaths occurred in first 48–72 h, mice were assessed at least
every 12 h over the first 4 days.
2.5 Histology
Skin from the region of the burn injury, including unburned
skin in the periphery, was excised and fixed in ice-cold
neutral-buffered formalin. Skin from sham-treated mice
was also taken for comparison. The skin was dehydrated,
embedded in paraffin, and sectioned. Sections were de-
waxed and stained with hematoxylin and eosin. Photographs
were taken on an Olympus light microscope.
2.6 Necropsy and tissue analysis
Mice were euthanized at different time points (7, 14, 21, and
30 days) under general anesthesia with 1–3% isoflurane
(inhaled) and supplemental oxygen followed by cardiac
puncture and cervical dislocation. Platelet poor plasma was
prepared from blood collected by cardiac puncture and
placed on ice in EDTA microtainers, followed by centrifu-
gation at 1,000×g for 15 min, removal of the plasma, and a
second centrifugation at 10,000×g for 10 min at 4°C.
Organs (liver, epididymal fat pad, spleen and heart) and
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muscles (gastrocnemius, quadriceps, and tibialis) were dis-
sected, weighed, and snap-frozen in liquid nitrogen as de-
scribed previously [20]. Carcasses were stripped of pelt and
organs and stored frozen at −80°C for later analysis. Lean
and fat carcass mass, bone mineral density, and bone min-
eral content were subsequently determined on thawed,
stripped carcasses using the Lunar PIXImus II (GE Medical
Systems), a fast, dual X-ray densitometer optimized for
mice and rats.
2.7 Cross-sectional area quantification and western blotting
analysis
Tibialis muscles from 20% BSA burn and sham groups at
14 days were harvested, weighed, flash frozen in isopentane
cooled in liquid nitrogen, and sectioned via cryostat. Sec-
tions were stained with hematoxylin and eosin. Photographs
were taken with an Olympus© light microscope. Cross-
sectional areas of 600 and 587 tibialis muscle fibers in the
sham and burn groups, respectively, were quantified by an
investigator blinded to the sample identities using NIH
ImageJ. Analysis and graphing were performed with Prism
5.0 (GraphPad). For Murf-1 expression, whole quadricep
lysates were subjected to western blotting analysis as de-
scribed [21] using antibodies directed against Murf-1, SC-
32920 (Santa Cruz Biotechnology, Santa Cruz, CA, USA)
and AB57865 (Abcam, Cambridge, MA, USA) and
GAPDH 5174 (Cell Signaling, Beverly, MA, USA).
2.8 Serum analyte profiling
All samples were stored at −80°C until tested (Rules Based
Medicine, Austin, TX, USA). Platelet poor plasma samples
were thawed at room temperature, vortexed, spun at
13,000×g for 5 min for clarification, and 150 μL was
removed for multiple analyte profiling (MAP) antigen anal-
ysis into a master microtiter plate. Using automated pipet-
ting, an aliquot of each sample was introduced into one of
the capture microsphere multiplexes of the RodentMAP 2.0.
These mixtures of sample and capture microspheres were
thoroughly mixed and incubated at room temperature for
1 h. Multiplexed cocktails of biotinylated reporter antibod-
ies for each multiplex were then added robotically and, after
thorough mixing, were incubated for an additional hour at
room temperature. Multiplexes were developed using an
excess of streptavidin–phycoerythrin solution, which was
thoroughly mixed into each multiplex and incubated for
1 h at room temperature. The volume of each multiplexed
reaction was reduced by vacuum filtration and the volume
increased by dilution into matrix buffer for analysis. Anal-
ysis was performed in a Luminex 100 instrument, and the
resulting data stream was interpreted using proprietary data
analysis software developed at Rules-Based Medicine and
licensed to Qiagen Instruments. For each multiplex, both
calibrators and controls were included on each microtiter
plate. Eight-point calibrators were run in the first and last
column of each plate, and three-level controls were in-
cluded in duplicate. Testing results were determined first
for the high, medium, and low controls for each multiplex
to ensure proper assay performance. Unknown values for
each of the analytes localized in a specific multiplex were
determined using four- and five-parameter, weighted, and
non-weighted curve fitting algorithms included in the data
analysis package.
2.9 Statistical analysis
Data analysis was carried out using GraphPad Prism Version
5.0. The Kaplan–Meier method was used to evaluate overall
survival and log-rank (Mantel–Cox) was used for compari-
sons between groups. Repeated measures two-way ANOVA
was used for body weight comparisons. Two-way ANOVA
with Bonferroni post-test was used to evaluate differ-
ences by treatment group and time point for endpoint
studies. Student’s unpaired t test was used to compare
plasma analyte levels between burned and sham groups. Data
are reported as mean±standard deviation. A P value of <0.05
was considered significant for all analysis.
3 Results
3.1 Effects of contact time, percentage burn
and resuscitation on survival
We sought to characterize a model of reproducible burn-
injury-associated weight loss without excessive mortality.
C57BL/6J mice were chosen in order to provide a baseline
characterization in a strain commonly used for generating and
maintaining transgenic and knockout lines. Young adult (12–
16 weeks old) male mice in the plateau phase of growth were
used. This age range was selected to ensure that the burn-
induced muscle wasting represented loss of muscle mass
rather than growth inhibition as might be observed with youn-
ger mice. Males were used exclusively due to early indications
of a sex difference in survival, with males exhibiting a reduced
overall survival as compared to females (data not shown).
Mice were anesthetized, shaved, depilated, dried, and
weighed. A burn of the required size was inflicted using a
combination of brass plates of several sizes held in direct
contact with the mouse skin in dorsal and lateral flank
positions (Fig. 1a, b). In initial trials, the time of contact
between the brass plate and the skin was varied, and the
burned skin and underlying musculature were evaluated by
histology (Fig. 2) and for survival (Fig. 3a). Hematoxylin
and eosin staining of mouse skin collected 7 days after burn
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injury confirmed that full-thickness burns resulted from 5 s
or greater of contact time. While in normal skin, the epider-
mis, dermis, hair follicle, sebaceous gland, and muscle are
normal and intact, 5 s of contact resulted in necrosis of the
epidermis, dermis, and dermal components without appar-
ently affecting underlying muscle. In contrast, 10 or 15 s of
contact time resulted in sloughing of the dermis, significant
lymphocytic infiltrate and fracturing, fatty change, and
necrosis of the skeletal muscle layer (Fig. 2). Because wewere
interested in systemic weight loss and muscle wasting rather
than local muscle injury, 5 s of contact time was used in all
subsequent experiments and in the final model.
Next, survival rates after burn injury in mice with differing
contact time and percentage burn were determined (Fig. 3a).
As in humans, murine survival following burn injury was
directly related to percentage BSA burned. Contact times of
Fig. 1 Burn injury model. Red
boxes indicate approximate are
of plate placement on the dorsal
aspect on either side of the
vertebral column, avoiding the
spine; however, lateral
placement might also be
necessary depending upon
mouse total BSA and desired
percent burn (a). Brass plates
(1×2×0.25 and 2×2×0.25 cm)
mounted on Teflon rods used
for burn injury (b)
Fig. 2 Increased skin contact time with heated brass plates results in
increased injury to the skin and underlying muscle. Hematoxylin and
eosin staining ofmouse skin 7 days after sham treatment (no burn) or after
burn injury with the indicated contact time with heated brass plates.
Normal skin (no burn) with epidermis, papillary and reticular dermis,
hair follicles, sebaceous glands, subcutis, and muscle is labeled. Mouse
skin subjected to 5 s of contact time exhibited loss of epidermis, non-
viable dermis, with increased lymphocytic infiltration but absence of
muscular involvement. With 10- and 15-s contact times, absence of the
epidermis, sloughing of the dermis, and a significant lymphocytic infil-
tration are visible along with underlying muscle damage
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10 s or longer resulted in 100%mortality, regardless of % BSA
burned. With 5 s of contact time and 15%BSA burned, greater
than 80% survival was observed. With 5 s of contact time and
20% BSA burned, greater than 50% survival was observed.
We next sought to evaluate the effect of fluid resuscitation
on overall survival in the 5-s contact time and 20% BSA burn
injury. Immediately after burn, animals were resuscitated with a
single intra-peritoneal injection with 2 cc/kg/%BSA, 4 cc/kg/%
BSA, and 6 cc/kg/% BSA of lactated ringers. In other studies,
additional fluid was given 12 h after burn injury. No differences
in gross behavior or overall survival were observed among
groups (data not shown).
Based upon these results, a longer-term study of 5-s, 20%
BSA burn, with 2 cc/kg/% BSA of lactated ringers resusci-
tation was undertaken. All mortalities in this model occurred
in the first 5 days with no subsequent mortalities noted out
to 30 days (n048) (Fig. 3b).
3.2 Weight loss and muscle wasting
Weight loss was observed in both the 20% BSA burn and
sham groups (Fig. 4a). Both groups demonstrate early
weight loss, possibly due to reduced food intake as a
result of buprenorphine treatment [in support of this,
treatment of sham mice with buprenorphine resulted in
an average 6.5% loss of body weight over 2 days versus
carrier treated mice due to a ∼40% reduction in food
intake over the first day (unpublished data)]. While sham-
treated mice regained the lost weight, burned mice did not;
rather, they experienced an average 5% (range 5–15%) reduc-
tion in total body weight out to 30 days. The nadir for body
weight in burnedmicewas 14 days, when total bodymass was
92.6% of sham mice.
A time course analysis was performed to determine
changes in body composition following burn injury. Mice
were sacrificed at 7, 14, 21, and 30 days following burn
injury or sham treatment and muscle and lean carcass mass
were measured (Fig. 4b–e). The results indicated that the
modest reduction in body weight in burned mice masked
marked changes in body composition. Skeletal muscle mass
was disproportionately reduced in animals receiving burns
both by weight of individual muscle groups (Fig. 4b–d) as
well as by Piximus analysis of the eviscerated, skinned
carcass (Fig. 4e). The nadir of individual muscle masses
appeared to be at 14 days. At this time, lean carcass mass
had declined to 88.5%, while individual muscles were re-
duced to 70% (tibialis) of shams. Overall, lean carcass mass
was most reduced at 7 days. Muscle and lean carcass loss
persisted through the 30-day time point.
The tibialis muscle at 14 days was used to determine
whether the reduction in muscle weight and LBM in burn
mice was attributable to a reduction in overall muscle fiber
cross-sectional area (Fig. 5). When compared to the sham
mice, the burn mice exhibited a 30% reduction in tibialis
muscle mass (P<0.001) and a 12% reduction in muscle fiber
cross-sectional area (P<0.001) (Fig. 5b, c). Consistent with
an overall reduction in fiber sizes, the distribution of muscle
fiber cross-sectional areas was shifted leftward in the burn
group (Fig. 5d). Consistent with prior reports of enhanced
expression of the RNA for the skeletal muscle-specific
ubiquitin ligase MuRF-1 [22], muscle wasting was associ-
ated with increased expression of proteins reacting MuRF-1-
specific antibodies in western blotting analysis (Fig. 5e).
3.3 Weight, food, and water intake (0–80 days)
The sham group followed a normal growth curve after
recovery of the initial weight loss due to buprenorphine
administration. In contrast, the burn group exhibited a pro-
longed period of weight loss, with recovery of initial body
weight at 35 days (Fig. 6a). At 80 days, the burn mice
exhibited a 7% reduction in body weight compared to sham
mice. Despite the reduced body weight, burned mice
exhibited persistently increased water intake (90% greater
than sham mice at 80 days), greatest at 4 days (156% greater
Fig. 3 Mortality is dependent upon % BSA burned and duration of
skin-plate contact time. Kaplan–Meier curve shows reduced survival
with increased percent body surface area (% BSA) burned and in-
creased contact times (a). Thirty-day survival curve comparing sham
to 20% BSA burn with 5 s contact time shows reduced overall survival
(60%), with the majority of deaths occurring in the first 5–6 days
following burn (b). Survival comparisons by log-rank (Mantel–Cox) test
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than sham mice on day 4), and consuming overall twice
as much water during the study period (Fig. 6b). The
burn group also exhibited increased food intake for the
duration of the study (44% greater than sham mice at
80 days), greatest at 14 days (188% greater than sham
mice on day 14) (Fig. 6c), with overall consumption
increased 74% over shams. The sham group showed
generally stable food and water intake for the duration
of 80 days, except on days 3–5 following buprenorphine
administration (Fig. 6b, c).
3.4 Altered body composition
Changes in adipose tissue were more complex. Epididymal
fat mass was significantly reduced from 14 through 30 days
(Fig. 7a). However, carcass fat mass, reflecting adipose
stores within muscle and cell membranes, was significantly
reduced only at 14 days (Fig. 7b). Significant decreases in
both bone mineral content (BMC) and bone mineral density
(BMD) were also observed (Fig. 7c, d), with the greatest
reductions at 14 days although reductions were trending
toward significance at 30 days. At the nadir for total body
weight of 14 days, fat mass had declined to 81.5% and bone
mineral density was reduced to 92.5% of shams. Balancing
the loss of muscle, fat and bone mass was hypertrophy of the
abdominal organs. As in patients, absolute liver mass as well
as liver to body mass ratios were increased after burn injury
(Fig. 7e, f). At 14 days, burned mice showed significantly
increased liver mass (117.5%) and liver to body mass ratios
(123.2%) relative to sham controls. Liver hypertrophy did
not resolve by 30 days. As well, spleen size was increased
both in terms of actual mass and as a percentage of body
weight through 30 days (Fig. 7g), while statistically signif-
icant hypertrophy of the heart was noted only at 14 and
21 days (Fig. 7h).
3.5 Serum profiling reveals acute phase response, increased
cytokines, and chemokines
In patients, muscle wasting and hepatomegaly after burn
have been linked to inflammation and heightened serum
cytokine levels. To probe these parameters, we performed
multiple analyte profiling on platelet poor plasma from
burned and sham-treated mice at 14 days, the nadir for
Fig. 4 Weight loss with
disproportionate muscle loss in
the 20% BSA burn model. Mice
with 20% burn and 5-s contact
time exhibited reduced overall
body weight (a), with dispro-
portionate reductions in quadri-
ceps, gastrocnemius, and lean
carcass mass (b–e). The nadir
of lean body and muscle mass
(quadriceps and gastrocnemius
shown) occurred at 14 days.
Starting weights were 7 days
sham 28.26±1.2 g, 7 days burn
27.85±1.1 g, 14 days sham
25.77±2.1 g, 14 days burn
26.83±1.7 g, 21 days sham
27.96±0.8 g, 21 days burn
28.06±1.1 g, 30 days sham
27.04±2.0 g, 30 days burn
25.90±2.1 g, with no signifi-
cant differences among groups.
Results are mean±SD. N06–27
per time point and group.
***P<0.001; **P<0.01;
*P<0.05
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muscle weight, BMD and BMC, and the peak of hepatos-
plenomegaly (Fig. 6). Of 59 serum proteins tested, 54 were
detectable above background. Of those, 23 demonstrated
statistically significant (defined as P<0.05) variance be-
tween the burn group versus the sham group, 19 of which
revealed differences that were greater than 1.5-fold or less
than 0.75-fold sham levels, chosen as the criteria for potential
biological significance.
In this analysis, the burned mice showed evidence of an
acute phase response. The serum acute phase response pro-
teins haptoglobin (3.66-fold), fibrinogen (2.82-fold), serum
amyloid P (SAP) (2.39-fold), and C-reactive protein (1.96-
fold) were all elevated. Consistent with these results, the
major activator of the acute phase response, interleukin-6
(IL-6) [23, 24] was greatly elevated in burned mice (32±
15 pg/mL) versus sham-treated mice, all of which had
undetectable IL-6 levels. Other cytokines that were in-
creased were CD40 ligand (1.73-fold) and oncostatin M
(1.62-fold).
Chemokine levels also differed in burned mice at 14 days.
Macrophage inflammatory protein (MIP)-2 (12.94-fold), KC-
GROalpha (10.21-fold), monocyte chemoattractant protein
(MCP)-5 (2.86-fold), MCP-3 (2.74-fold), MCP-1 (2.36-fold),
RANTES (2.31-fold), and MIP-1 gamma (1.78-fold) were all
increased. Of the growth factors measured, only vascular
endothelial cell growth factor was significantly changed
in burned mice to 1.53-fold. Of the other analytes
tested, only tissue inhibitor of metalloproteinase-1 (4.19-fold),
von Willebrand factor (3.05-fold), and myeloperoxidase
(3.31) met the definition of significantly changed.
4 Discussion
In 1942, Cuthbertson first described the metabolic derange-
ments in post-traumatic patients occurring in two phases, the
“ebb” phase resulted in an initial reduction in metabolism
which was followed by the “flow” phase, occurring 3–5 days
later and characterized by a hypermetabolic state that, if left
untreated, could lead to a physiologic exhaustion and death
[25, 26]. Such derangements in metabolism and body com-
position including muscle and bone loss as well as organo-
megaly after burn injury remain a significant cause of long-
term morbidity and mortality for patients [5, 26]. Under-
standing the signaling pathways governing these processes
should lead to therapeutic interventions that improve survival
and quality of life. Herein we describe a mouse model of burn
injury that reproduces the chronic human pathophysiological
Fig. 5 Muscle fiber wasting at
14 days. Hematoxylin and eosin
staining of tibialis anterior
sections in sham and burned
mice at 14 days (a). A 30%
reduction in tibialis mass (mean
weight±SD) was observed
14 days after 20% BSA burn
injury (P<0.001) (b).
Reduction in fiber cross-
sectional area (CSA) in tibialis
of burned mice (N0587 fibers
from four mice) versus sham
(N0600 fibers from three mice)
at 14 days (c). A histogram
shows the frequency distribu-
tion of muscle fiber CSA (d).
Western blotting analysis of
quadriceps lysate shows in-
creased anti-MuRF-1 antibody
immunoreactivity after burn
injury (e). Starting weights
were sham 31.21±2.6 and burn
32.74±1.25 g (N.S.).
***P<0.001
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response following severe burn. This description of chronic
peripheral wasting and organ hypertrophy in C57BL/6J mice
provides a baseline for future pharmacological and genetic
approaches to dissecting the molecular mechanisms underly-
ing burn-injury-associated cachexia.
Similar to clinical observations, the mouse exhibits in-
creased mortality with increasing percent BSA burned [7].
Furthermore, we observed that as contact time increased,
mortality increased precipitously (Fig. 3). Survival data taken
together with the histological data suggest that the length of
contact time is directly related to the depth of injury locally
and the magnitude of the response systemically. Ultimately we
settled upon 5 s of contact time to burn 20% of the BSA and
analyzed the mice out to 30 days.
This approach resulted in a 60% survival rate and modest
reductions in total body mass that mask a disproportionately
large loss of muscle and lean body mass, with a concomitant
reduction in muscle fiber cross sectional area (Figs. 4 and 5).
Loss of bone mineral content, bone mineral density, and fat
was also observed as in human burn patients [4] (Fig. 7).
Organomegaly after burn injury contributes to increased
total body weight, helping to mask the severity of wasting.
Similar to human subjects, liver hypertrophy was noted, and
moreover, increased weight of the gut and lungs was also
observed (data not shown) [13, 14, 26] (Fig. 7). The results
mimic changes observed in burn patients and reflect a shift
of amino acid and fat stores away from peripheral compart-
ments toward visceral compartments, ostensibly a pro-
survival mechanism to preserve abdominal organ function,
provide substrates for wound healing, and to promote the
immune response.
The burned mice also exhibited a profound and pro-
longed period of increased food and water intake up to
80 days which is consistent with the increased nutritional
requirements observed in severe burn patients who remain
hypermetabolic with increased resting energy expenditure
for up to 2 years following burn injury [4, 26] (Fig. 6). It has
been shown repeatedly that a lack of increased nutritional
support during this period reduces overall survival and
recovery in severe burn patients [27]. Also, the mice
exhibited a prolonged period of significant polydipsia out
to 80 days, likely attributable acutely to the water and heat
loss commonly found following burn (water loss can ap-
proach 4,000 mL/m2 burn area per day) and chronically due
to a persistent hypermetabolic state [26].
In addition to the pathophysiological changes and tem-
poral similarities, we also observe systemic inflammation as
in convalescent human burn patients. As reported in prior
studies in mice and humans with burn injury, coincident
with skeletal muscle and fat wasting and organ hypertrophy,
we observed an increase in levels of the cytokines, as well as
clear evidence of a chronic acute phase response, as repre-
sented by elevations in haptoglobin, fibrinogen, SAP, and
CRP [11, 14, 28] (Fig. 8). Such chronic inflammation is a
common observation across experimental and clinical cachex-
ia and is likely a root cause of the reduced body mass, muscle
and fat wasting, and organomegaly observed after burn injury.
Specifically IL-6 is significantly elevated in burn patients and
has been demonstrated to be a predictor of outcomes in
severely burned patients [26, 28]. In support of this theory,
systemic IL-6 treatment alone, in the absence of other injury or
treatment, promotes loss of total body weight, muscle mass,
and fat mass, along with profound hepatosplenomegaly and
increased gut, kidney, and lung mass [24, 29]. Which effects
Fig. 6 Twenty percent BSA burn leads to a prolonged reduction in
body weight despite chronic hyperphagia and polydipsia. Mice with
burn injury experienced significantly reduced body weight. Recovery
of starting body weight occurred at 35 days, but weight remained
reduced versus shams out to 80 days when the experiment was termi-
nated (a). Both daily water (b) and food (c) intake (mean±SD) were
significantly increased following 20% burn injury out to 80 days. Total
intake calculated as the area under the curve (AUC) for each mouse
was also increased (bar graphs). The mice in the burn group were
slightly larger at day 0, sham 25.67±0.3 g (N08) and burn 27.76±0.4
(N014) (p<0.01)
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on body composition are the direct effect of IL-6 signaling
and which are indirect is not altogether clear. In the case of
IL-6 treatment, however, the increase in liver mass was due
to both hepatocyte hypertrophy (necessary for the massive-
ly increased protein synthetic requirements for the acute
phase response) as well as hyperplasia, while the increase
in gut mass was due to inhibition of enterocyte apoptosis
[30–34]. IL-6 may also play a role in promoting muscle
catabolism directly in burn injury, as in other models of
muscle wasting [21].
Importantly, we also observe the long-term nature of
chronic body changes, inflammation, and nutritional
requirements measured in burn patients [4, 11] (Table 1).
The best approximations of rat age to human years indicate
that during the adult phase of life, 11.8 rat days is equivalent
to 1 human year [35]. Given that laboratory mice have
similar developmental and physiological benchmarks, the
2 to 4 weeks of muscle wasting we observe in mice would
be similar to wasting of 1.2 to 2.5 years duration in burn
patients [3, 4, 11].
While many investigators use murine models of burn inju-
ry, a single, complete description of post-burn cachexia in the
mouse was lacking in the literature. We sought to report our
experience and characterization to facilitate others’ adoption
of the model for anti-cachexia research. There are several
limitations to our study. One discrepancy between our mouse
model and human findings is our reduced overall survival
(60%) as compared to human 20% TBSA burn subjects who
historically exhibit survival of >90% [2]. Of course, our mice
are untreated, save initial anesthesia and fluid resuscitation,
Fig. 7 Fat and bone loss with
hepatosplenomegaly and
cardiac hypertrophy following
20% BSA burn. Epididymal fat
pad in 20% BSA burn is
significantly reduced starting
with day 14 and continuing
through 30 days (a). Total body
fat content by Piximus was
significantly reduced at 14 days
(b). Bone mineral density
(BMD) and bone mineral
content (BMC) by Piximus
were significantly reduced at
14 days (c–d). The nadir for fat
(epididymal, body fat mass),
BMD, and BMC occurred at
14 days, with concomitant peak
liver size (e–f). Spleen and heart
mass were also elevated after
burn (g–h). Results are mean±
SD. Starting weights are as in
Fig. 4. N06–27 per time point
and group. ***P<0.001;
**P<0.01; *P<0.05
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while patients with severe burn are intensively treated. Our
observed mortality is similar to that reported by some groups
using 25% BSA scald models [36]. Greater mortality than
others might be due to a combination of greater contact in this
study due to depilation and use of brass plates, differences in
calculating BSA, and conventional versus barrier housing;
however, as in patients, lethality and the presence of long-
term wasting were well correlated. Lower percentage burns
caused no deaths and no total body weight loss. We chose the
%BSA that resulted in a major physiological challenge,
sometimes resulted in death and always resulted in long-
term consequences for survivors. We chose to use contact
burn injury using plates of specific dimensions rather than
scald due to the greater control of percentage TBSA burned.
Scald models generally use a single mold that does not permit
varying the burn size. In contrast, our approach permits pre-
cise application of burn injury across age and weight ranges or
for mice of altered body shape and composition, including
obese, hypermuscular, or otherwise size-altered animals.
Cachexia is a devastating syndrome affecting trauma,
surgical, and critically or chronically ill patients, including
burn. However, the severity and chronicity of cachexia in
burn patients is unique. Several clinical studies have led to
therapeutic advancements for the treatment of the hyper-
catabolic state in the acute period following burn resulting
in improvements in the degree of cachexia chronically.
These therapies include propranolol [37], testosterone,
oxandrolone [38], recombinant human growth hormone,
insulin-like growth factor [39, 40], and growth hormone
[26, 41] with favorable outcomes. The exact mechanisms
behind the efficacy of these interventions, particularly
Table 1 Twenty percent TBSA burn in mice reproduces pathophysi-
ological changes observed in human burn injury
Human Mouse
Burn size 53% 20%
3rd degree burn size 43% 20%
Length of hospital stay 31 days 14 days





Liver mass +80–120% +34–50%




Acute phase reactants Elevated Elevated
Evidence of
hypermetabolism
Increased REE Hyperphagic but
weight stable
Caloric intake 1,500 kcal/m2 BSA ∼6,000 kcal/m2
+1,500 kcal/m2 burn
1.25-fold RDI 3-fold normal
Duration of hypermetabolism Up to 2 years At least 80 days
Duration of wasting Up to 2 years At least 80 days
Pathophysiologic changes in mice with 20% TBSA burn at 14 days as
compared to those found in human burn subjects (11)
LBM lean body mass, FBM fat body mass, BMC bone mineral content,
BMD bone mineral density
Fig. 8 Twenty percent BSA
burn injury leads to increases in
plasma acute phase proteins,
chemokines, and cytokines.
Multiple analyte profiling was
performed on platelet-poor
plasma in sham and 20% BSA
burn mice at 14 days. Results
are mean±SD, ***P<0.001;
**P<0.01; *P<0.05
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propanolol and anabolic steroids, are largely unknown and
need to be further studied. The baseline data we present
on long-term changes after burn injury in the C57BL/6J
mouse can provide a baseline for future studies of burn-
injury-associated cachexia in evaluating the efficacy of
therapeutic or molecular interventions and in genetically
modified mice.
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